Intelligent Investor

Australian Clinical Labs Limited (ASX: ACL) - Announcements

- Current share price for ACL : $2.210

ASX company news and announcements for Australian Clinical Labs Limited (ACL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Clinical Labs Limited (ACL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Clinical Labs Limited (ACL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Clinical Labs Limited (ACL)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$446 Becoming a substantial holder 23 May 2024 8:19AM $2.210 $2.210 $2.300 fallen by 0%
$446 Change in substantial shareholding from AEF 22 May 2024 9:20AM $2.330 $2.210 $2.300 fallen by 5.15%
$446 FY24 Trading Update 21 May 2024 10:14AM $2.240 $2.210 $2.300 fallen by 1.34%
$446 Becoming a substantial holder from MUFG 20 May 2024 3:58PM $2.330 $2.210 $2.300 fallen by 5.15%
$446 Becoming a substantial holder 17 May 2024 6:32PM $2.300 $2.210 $2.300 fallen by 3.91%
$446 Change in substantial shareholding from AEF 13 May 2024 3:27PM $2.435 $2.210 $2.300 fallen by 9.24%
$446 Ceasing to be a substantial holder from MUFG 10 May 2024 4:49PM $2.430 $2.210 $2.300 fallen by 9.05%
$446 Ceasing to be a substantial holder 9 May 2024 4:31PM $2.430 $2.210 $2.300 fallen by 9.05%
$446 Becoming a substantial holder from MUFG 7 May 2024 6:01PM $2.480 $2.210 $2.300 fallen by 10.89%
$446 Becoming a substantial holder 6 May 2024 6:17PM $2.460 $2.210 $2.300 fallen by 10.16%
$446 Notification of cessation of securities - ACL 3 May 2024 4:34PM $2.440 $2.210 $2.300 fallen by 9.43%
$446 Change in substantial shareholding from AEF 3 May 2024 12:09PM $2.430 $2.210 $2.300 fallen by 9.05%
$446 Ceasing to be a substantial holder from MUFG 24 Apr 2024 5:04PM $2.490 $2.210 $2.300 fallen by 11.24%
$446 Ceasing to be a substantial holder 23 Apr 2024 4:24PM $2.440 $2.210 $2.300 fallen by 9.43%
$446 Becoming a substantial holder from MUFG 22 Apr 2024 5:32PM $2.410 $2.210 $2.300 fallen by 8.30%
$446 Becoming a substantial holder 19 Apr 2024 4:19PM $2.370 $2.210 $2.300 fallen by 6.75%
$446 Ceasing to be a substantial holder from MUFG 12 Apr 2024 4:45PM $2.520 $2.210 $2.300 fallen by 12.30%
$446 Ceasing to be a substantial holder 11 Apr 2024 5:42PM $2.540 $2.210 $2.300 fallen by 12.99%
$446 Becoming a substantial holder from MUFG 25 Mar 2024 7:31PM $2.630 $2.210 $2.300 fallen by 15.97%
$446 Ceasing to be a substantial holder from MUFG 14 Mar 2024 6:32PM $2.530 $2.210 $2.300 fallen by 12.65%
$446 Ceasing to be a substantial holder 13 Mar 2024 5:49PM $2.580 $2.210 $2.300 fallen by 14.34%
$446 Becoming a substantial holder from MUFG 8 Mar 2024 8:11PM $2.640 $2.210 $2.300 fallen by 16.29%
$446 Ceasing to be a substantial holder from MUFG 7 Mar 2024 7:30PM $2.560 $2.210 $2.300 fallen by 13.67%
$446 Becoming a substantial holder 7 Mar 2024 6:32PM $2.560 $2.210 $2.300 fallen by 13.67%
$446 Becoming a substantial holder from MUFG 6 Mar 2024 7:30PM $2.560 $2.210 $2.300 fallen by 13.67%

1 - 25 of 579 results

Page 1 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.